PeptiDream Inc.
TSE:4587.T
2467.5 (JPY) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 28,712.194 | 26,852.43 | 9,365.964 | 11,677.253 | 2,074.674 | 7,216.622 | 6,426.891 | 4,895.747 | 4,327.878 | 2,474.499 | 818.901 | 678.269 | 269.004 |
| Cost of Revenue
| 11,849.651 | 8,738.942 | 2,358.013 | 2,147.904 | 1,413.612 | 1,651.254 | 1,778.626 | 1,359.801 | 1,086.291 | 721.639 | 314.763 | 267.579 | 167.422 |
| Gross Profit
| 16,862.543 | 18,113.488 | 7,007.951 | 9,529.349 | 661.062 | 5,565.368 | 4,648.265 | 3,535.946 | 3,241.587 | 1,752.86 | 504.138 | 410.69 | 101.582 |
| Gross Profit Ratio
| 0.587 | 0.675 | 0.748 | 0.816 | 0.319 | 0.771 | 0.723 | 0.722 | 0.749 | 0.708 | 0.616 | 0.605 | 0.378 |
| Reseach & Development Expenses
| 3,155.366 | 2,915.118 | 1,654.429 | 1,460.973 | 1,786.534 | 0 | 921.343 | 362.681 | 228.212 | 88.549 | 0 | 0 | 0 |
| General & Administrative Expenses
| 7,256.195 | 6,220.618 | 1,354.534 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| -951.532 | 1,271 | -218.56 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 6,304.663 | 6,220.618 | 1,135.974 | 1,007.668 | 648.864 | 0 | 748.433 | 676.932 | 464.796 | 272.804 | 302.775 | 249.879 | 0 |
| Other Expenses
| -227.235 | -2.444 | 2,589.807 | 2,538.025 | 0 | 1,985.585 | 1,737.283 | 1,045.53 | 1.507 | 0.2 | 0.345 | -14.659 | 7.986 |
| Operating Expenses
| 9,687.264 | 9,133.292 | 2,589.807 | 2,538.025 | 2,435.398 | 1,985.585 | 1,737.283 | 1,045.53 | 693.506 | 361.733 | 302.775 | 249.879 | 119.754 |
| Operating Income
| 7,175.279 | 8,980.196 | 4,418.143 | 6,991.323 | -1,774.336 | 3,579.781 | 2,910.98 | 2,490.415 | 2,548.08 | 1,391.126 | 201.362 | 160.81 | -18.172 |
| Operating Income Ratio
| 0.25 | 0.334 | 0.472 | 0.599 | -0.855 | 0.496 | 0.453 | 0.509 | 0.589 | 0.562 | 0.246 | 0.237 | -0.068 |
| Total Other Income Expenses Net
| -2,464.263 | -2,326.871 | 405.509 | -971.298 | 361.262 | 227.071 | 240.75 | 133.744 | -182.269 | 102.248 | 20.63 | 13.309 | -3.375 |
| Income Before Tax
| 4,711.016 | 6,653.325 | 4,823.652 | 6,020.025 | -1,413.074 | 3,806.852 | 3,151.73 | 2,624.159 | 2,365.811 | 1,493.374 | 221.992 | 174.119 | -21.548 |
| Income Before Tax Ratio
| 0.164 | 0.248 | 0.515 | 0.516 | -0.681 | 0.528 | 0.49 | 0.536 | 0.547 | 0.604 | 0.271 | 0.257 | -0.08 |
| Income Tax Expense
| 1,317.636 | -901.033 | 1,217.244 | 1,571.668 | -436.146 | 1,036.71 | 816.513 | 733.408 | 784.522 | 489.21 | 73.479 | 36.939 | -31.519 |
| Net Income
| 3,035.832 | 7,554.358 | 3,606.407 | 4,448.357 | -976.928 | 2,770.141 | 2,335.216 | 1,890.75 | 1,581.288 | 1,004.164 | 148.512 | 137.18 | 9.971 |
| Net Income Ratio
| 0.106 | 0.281 | 0.385 | 0.381 | -0.471 | 0.384 | 0.363 | 0.386 | 0.365 | 0.406 | 0.181 | 0.202 | 0.037 |
| EPS
| 23.41 | 58.19 | 27.98 | 35.4 | -7.8 | 22.42 | 19.35 | 16.54 | 14.23 | 9.18 | 1.39 | 1.54 | 0.12 |
| EPS Diluted
| 23.38 | 58.14 | 27.76 | 34.26 | -7.8 | 21.33 | 17.79 | 14.56 | 12.26 | 7.83 | 1.39 | 1.23 | 0.12 |
| EBITDA
| 9,608.461 | 10,939.347 | 5,001.974 | 8,518.591 | -1,261.798 | 4,101.262 | 3,427.079 | 2,685.576 | 2,697.58 | 1,497.231 | 275.104 | 213.176 | 23.381 |
| EBITDA Ratio
| 0.335 | 0.407 | 0.534 | 0.73 | -0.608 | 0.568 | 0.533 | 0.549 | 0.623 | 0.605 | 0.336 | 0.314 | 0.087 |